Baxter International Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Baxter International Inc. on February 16, 2021, covering events reported as of February 14, 2021. The filing details significant changes to the composition and leadership of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Board Retirement: Dr. James R. Gavin III, M.D., Ph.D., notified the Company of his retirement from the Board, the Nominating, Corporate Governance & Public Policy Committee, and the Quality, Compliance and Technology Committee, effective May 2, 2021.
- New Director Appointment: Dr. David S. Wilkes, M.D., was appointed to the Board and the Quality, Compliance and Technology Committee effective February 15, 2021. His initial term expires at the 2021 Annual Meeting.
- Board Size Adjustment: The Board size was temporarily increased to 13 directors effective February 15, 2021, to accommodate Dr. Wilkes. It will decrease to 12 directors upon Dr. Gavin's retirement in May 2021.
- Leadership Changes: Mr. Albert P.L. Stroucken was appointed Lead Independent Director, succeeding Mr. Thomas T. Stallkamp. Mr. Thomas Chen will chair the Nominating, Corporate Governance & Public Policy Committee following Dr. Gavin's departure. Ms. Cathy Smith was appointed Chair of the Audit Committee.
Guidance, Outlook, and Compensation
Dr. Wilkes will be compensated under the Non-Employee Director Compensation Plan and is eligible for the Directors' Deferred Compensation Plan. He received prorated equity awards for the period between his appointment and the 2021 Annual Meeting. The filing contains no financial guidance, risk factors, or management commentary regarding business outlook.
Key Facts for Investor Verification
- Confirm the effective dates of Dr. Gavin's retirement (May 2, 2021) and Dr. Wilkes' appointment (February 15, 2021).
- Verify the new committee chair assignments: Mr. Thomas Chen (Nominating, Corporate Governance & Public Policy) and Ms. Cathy Smith (Audit).
- Note the temporary increase in Board size to 13 members before reverting to 12.
- Review the attached press release (Exhibit 99.1) for additional context on the appointments.